Berkeley Capital Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.07M | Sell |
17,179
-5,486
| -24% | -$633K | 0.48% | 38 |
|
|
2025
Q4 | $2.39M | Sell |
22,665
-1,153
| -5% | -$108K | 0.56% | 27 |
|
|
2025
Q3 | $2M | Buy |
23,818
+907
| +4% | +$74.7K | 0.47% | 36 |
|
|
2025
Q2 | $1.81M | Buy |
22,911
+537
| +2% | +$42.7K | 0.46% | 41 |
|
|
2025
Q1 | $2.01M | Buy |
22,374
+11,928
| +114% | +$1.11M | 0.55% | 34 |
|
|
2024
Q4 | $1.04M | Sell |
10,446
-7,247
| -41% | -$747K | 0.29% | 73 |
|
|
2024
Q3 | $2.01M | Buy |
17,693
+12,839
| +265% | +$1.53M | 0.57% | 29 |
|
|
2024
Q2 | $601K | Buy |
4,854
+499
| +11% | +$64.3K | 0.18% | 101 |
|
|
2024
Q1 | $575K | Sell |
4,355
-11,811
| -73% | -$1.46M | 0.18% | 100 |
|
|
2023
Q4 | $1.76M | Sell |
16,166
-169
| -1% | -$17.5K | 0.58% | 28 |
|
|
2023
Q3 | $1.68M | Buy |
16,335
+201
| +1% | +$21.7K | 0.61% | 29 |
|
|
2023
Q2 | $1.86M | Buy |
16,134
+1,475
| +10% | +$167K | 0.66% | 27 |
|
|
2023
Q1 | $1.56M | Buy |
14,659
+21
| +0.1% | +$2.27K | 0.58% | 31 |
|
|
2022
Q4 | $1.62M | Sell |
14,638
-244
| -2% | -$24.9K | 0.63% | 30 |
|
|
2022
Q3 | $1.28M | Buy |
14,882
+3,229
| +28% | +$288K | 0.55% | 28 |
|
|
2022
Q2 | $1.06M | Buy |
11,653
+1,643
| +16% | +$146K | 0.44% | 40 |
|
|
2022
Q1 | $821K | Buy |
10,010
+5,487
| +121% | +$433K | 0.33% | 60 |
|
|
2021
Q4 | $347K | Buy |
4,523
+1,347
| +42% | +$107K | 0.14% | 99 |
|
|
2021
Q3 | $239K | Buy |
+3,176
| New | +$242K | 0.11% | 120 |
|
|
2021
Q1 | – | Sell |
-3,248
| Closed | -$253K | – | 131 |
|
|
2020
Q4 | $253K | Sell |
3,248
-706
| -18% | -$54K | 0.13% | 100 |
|
|
2020
Q3 | $313K | Buy |
+3,954
| New | +$310K | 0.19% | 75 |
|
|
2020
Q2 | – | Sell |
-7,140
| Closed | -$524K | – | 111 |
|
|
2020
Q1 | $524K | Buy |
7,140
+2,215
| +45% | +$174K | 0.36% | 60 |
|
|
2019
Q4 | $427K | Sell |
4,925
-558
| -10% | -$45.8K | 0.22% | 87 |
|
|
2019
Q3 | $440K | Buy |
5,483
+995
| +22% | +$79.7K | 0.23% | 83 |
|
|
2019
Q2 | $359K | Buy |
4,488
+367
| +9% | +$28.1K | 0.17% | 100 |
|
|
2019
Q1 | $327K | Sell |
4,121
-41
| -1% | -$3.07K | 0.16% | 106 |
|
|
2018
Q4 | $303K | Sell |
4,162
-244
| -6% | -$17.2K | 0.17% | 102 |
|
|
2018
Q3 | $298K | Buy |
4,406
+60
| +1% | +$3.82K | 0.17% | 98 |
|
|
2018
Q2 | $251K | Sell |
4,346
-4,175
| -49% | -$236K | 0.15% | 109 |
|
|
2018
Q1 | $442K | Sell |
8,521
-1,149
| -12% | -$62.1K | 0.26% | 83 |
|
|
2017
Q4 | $519K | Buy |
9,670
+5,704
| +144% | +$316K | 0.34% | 74 |
|
|
2017
Q3 | $242K | Buy |
+3,966
| New | +$240K | 0.16% | 109 |
|
|
2017
Q1 | – | Sell |
-4,472
| Closed | -$251K | – | 120 |
|
|
2016
Q4 | $251K | Sell |
4,472
-236
| -5% | -$13.8K | 0.18% | 99 |
|
|
2016
Q3 | $280K | Sell |
4,708
-3,966
| -46% | -$232K | 0.2% | 89 |
|
|
2016
Q2 | $477K | Sell |
8,674
-3,363
| -28% | -$179K | 0.33% | 69 |
|
|
2016
Q1 | $608K | Buy |
12,037
+4,381
| +57% | +$215K | 0.44% | 53 |
|
|
2015
Q4 | $386K | Buy |
+7,656
| New | +$386K | 0.31% | 66 |
|
Other funds holding MRK
VCM
VPM
Berkeley Capital Partners's MRK Position: Q1 2026 in Review
Berkeley Capital Partners reduced its Merck (MRK) stake by 24% in Q1 2026, selling an estimated $633K and leaving 17,179 shares worth $2.07M. The position accounts for 0.48% of the portfolio, ranked #38.
Berkeley Capital Partners first reported a position in MRK in Q4 2015 and has held it in 37 quarters since. The position peaked at $2.39M in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Berkeley Capital Partners held 17,179 shares of Merck worth $2.07M as of Q1 2026.
- Berkeley Capital Partners sold 5,486 Merck shares in Q1 2026, an estimated $633K.
- Merck made up 0.48% of Berkeley Capital Partners's portfolio in Q1 2026, its #38 holding.
- Berkeley Capital Partners first reported a position in Merck in Q4 2015 and has held it in 37 quarters since.
- Berkeley Capital Partners's Merck position peaked at $2.39M in Q4 2025.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Berkeley Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.